The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of thrombosis and stenosis are listed in the absolute pro.035 peripheral self-expanding stent system instructions for use (ifu) as adverse events that may be associated with the use of a stent in peripheral arteries.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
Patient id: (b)(6).It was reported that the patient underwent a stenting procedure on (b)(6) 2022 with implant of a 6.0 x 100 mm absolute pro stent in the mid right superficial femoral artery.One day post procedure, thrombus was noted in the stented lesion, with restenosis noted due to the volume of thrombus.Thrombectomy was performed and the event resolved one day later.No additional information was provided.
|